TSE:QIPT Quipt Home Medical (QIPT) Stock Price, News & Analysis C$3.12 -0.08 (-2.50%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock About Quipt Home Medical Stock (TSE:QIPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Quipt Home Medical alerts:Sign Up Key Stats Today's RangeC$3.12▼C$3.2550-Day RangeC$2.37▼C$3.2052-Week RangeC$1.90▼C$4.99Volume6,705 shsAverage Volume27,152 shsMarket CapitalizationC$94.53 millionP/E RatioN/ADividend YieldN/APrice TargetC$7.50Consensus RatingBuy Company Overview Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily & Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea & PAP Treatment. Read More Receive QIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address QIPT Stock News HeadlinesQIPT - Quipt Home Medical Corp Executives - MorningstarJune 26, 2025 | morningstar.comMForager Capital Management Denies its Offer was Unsolicited and Requests that Quipt Terminate its Standstill AgreementJune 4, 2025 | finance.yahoo.comMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alternative Assets reveals 3 urgent moves to protect your portfolio, plus the #1 asset class thriving during crises (hint: it’s not stocks or bonds).August 5 at 2:00 AM | American Alternative (Ad)Quipt Home Medical Gets Unsolicited Acquisition Offer From Forager Despite Standstill AgreementMay 23, 2025 | nasdaq.comQuipt Home Medical Corp. (QIPT) Q2 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comQuipt Home Medical price target lowered to C$7 from C$7.50 at StifelJanuary 28, 2025 | markets.businessinsider.comQuipt Home Medical price target lowered to $6 from $7 at BenchmarkDecember 22, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Quipt Home Medical (QIPT)November 28, 2024 | markets.businessinsider.comSee More Headlines QIPT Stock Analysis - Frequently Asked Questions How have QIPT shares performed this year? Quipt Home Medical's stock was trading at C$4.38 at the beginning of 2025. Since then, QIPT shares have decreased by 28.8% and is now trading at C$3.12. How do I buy shares of Quipt Home Medical? Shares of QIPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Quipt Home Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quipt Home Medical investors own include AbCellera Biologics (ABCL), Avino Silver & Gold Mines (ASM), ASML (ASML), Broadcom (AVGO), Booking (BKNG) and Boralex (BLX). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Devices Sub-IndustryHealthcare Current SymbolTSE:QIPT CIKN/A Webquipthomemedical.com Phone859-878-2220FaxN/AEmployees800Year FoundedN/APrice Target and Rating Average Price Target for Quipt Home MedicalC$7.50 High Price TargetC$7.50 Low Price TargetC$7.50 Potential Upside/Downside+140.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)C($0.24) Trailing P/E RatioN/A Forward P/E Ratio45.58 P/E GrowthN/ANet Income-C$5.16 million Net Margins-3.00% Pretax MarginN/A Return on Equity-6.70% Return on Assets1.15% Debt Debt-to-Equity Ratio94.74 Current Ratio1.22 Quick RatioN/A Sales & Book Value Annual SalesC$171.98 million Price / Sales0.55 Cash FlowN/A Price / Cash FlowN/A Book ValueC$2.49 per share Price / Book1.25Miscellaneous Outstanding Shares30,299,217Free FloatN/AMarket CapC$94.53 million OptionableNot Optionable Beta1.01 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (TSE:QIPT) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quipt Home Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quipt Home Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.